文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

RECOURSE研究:机器人辅助微创手术在子宫内膜癌、宫颈癌、结直肠癌、肺癌或前列腺癌中的长期肿瘤学结局:系统综述与Meta分析

The RECOURSE Study: Long-term Oncologic Outcomes Associated With Robotically Assisted Minimally Invasive Procedures for Endometrial, Cervical, Colorectal, Lung, or Prostate Cancer: A Systematic Review and Meta-analysis.
PubMed 文献 · Ann Surg · 2022-09-08

该系统综述与Meta分析基于199项研究(7项随机、23项数据库、15项前瞻性、154项回顾性),纳入157,876例机器人、68,007例腹腔镜/胸腔镜和234,649例开放手术病例,评估多种癌症的长期肿瘤学结局。结果显示机器人手术与腹腔镜/胸腔镜及开放手术的长期结局总体相似,未发现需进一步研究的安全性信号或适应证。

要点

  • 宫颈癌:机器人与腹腔镜或开放手术的总生存(OS)和无病生存(DFS)相似。

核心结论

  • 机器人手术与腹腔镜/胸腔镜及开放手术的长期肿瘤学结局总体相似,未发现安全性信号或需进一步研究的适应证。

研究设计与样本

  • 系统综述与Meta分析,遵循PRISMA指南,检索Pubmed、Scopus和Embase,最终纳入199项研究(7项随机、23项数据库、15项前瞻性、154项回顾性),共157,876例机器人、68,007例腹腔镜/胸腔镜和234,649例开放手术病例。

主要发现

  • 宫颈癌:机器人与腹腔镜的OS和DFS相似[1.01 (0.56, 1.80), P=0.98],与开放手术的OS相似[1.18 (0.99, 1.41), P=0.06];2篇论文报告开放手术复发更少[2.30 (1.32, 4.01), P=0.003]。
  • 子宫内膜癌:唯一显著结果支持机器人优于开放手术[OS; 0.77 (0.71, 0.83), P<0.001]。
  • 肺叶切除术:机器人对比胸腔镜的DFS更优[0.74 (0.59, 0.93), P=0.009];机器人对比开放手术的OS更优[0.93 (0.87, 1.00), P=0.04]。
  • 前列腺切除术:机器人对比腹腔镜的复发更少[0.77 (0.68, 0.87), P<0.0001];机器人对比开放手术的OS更优[0.78 (0.72, 0.85), P<0.0001]。
  • 低位前切除术:机器人对比腹腔镜的OS显著更优[0.76 (0.63, 0.91), P=0.004],对比开放手术的OS也显著更优[0.83 (0.74, 0.93), P=0.001]。

临床怎么用

  • 对于宫颈癌、子宫内膜癌、结直肠癌、肺癌和前列腺癌,机器人手术可作为与腹腔镜/胸腔镜或开放手术相当的选项,长期肿瘤学结局总体相似。
  • 在子宫内膜癌、肺叶切除术、前列腺切除术和低位前切除术中,机器人手术在部分结局上显示出优于开放或腹腔镜手术的优势,可结合患者具体情况个体化选择。

局限性

  • 纳入研究以回顾性为主(154项),仅7项随机对照试验,可能存在选择偏倚和混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess long-term outcomes with robotic versus laparoscopic/thoracoscopic and open surgery for colorectal, urologic, endometrial, cervical, and thoracic cancers. BACKGROUND: Minimally invasive surgery provides perioperative benefits and similar oncological outcomes compared with open surgery. Recent robotic surgery data have questioned long-term benefits. METHODS: A systematic review and meta-analysis of cancer outcomes based on surgical approach was conducted based on Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines using Pubmed, Scopus, and Embase. Hazard ratios for recurrence, disease-free survival (DFS), and overall survival (OS) were extracted/estimated using a hierarchical decision tree and pooled in RevMan 5.4 using inverse-variance fixed-effect (heterogeneity nonsignificant) or random effect models. RESULTS: Of 31,204 references, 199 were included (7 randomized, 23 database, 15 prospective, 154 retrospective studies)-157,876 robotic, 68,007 laparoscopic/thoracoscopic, and 234,649 open cases. Cervical cancer: OS and DFS were similar between robotic and laparoscopic [1.01 (0.56, 1.80), P =0.98] or open [1.18 (0.99, 1.41), P =0.06] surgery; 2 papers reported less recurrence with open surgery [2.30 (1.32, 4.01), P =0.003]. Endometrial cancer: the only significant result favored robotic over open surgery [OS; 0.77 (0.71, 0.83), P <0.001]. Lobectomy: DFS favored robotic over thoracoscopic surgery [0.74 (0.59, 0.93), P =0.009]; OS favored robotic over open surgery [0.93 (0.87, 1.00), P =0.04]. Prostatectomy: recurrence was less with robotic versus laparoscopic surgery [0.77 (0.68, 0.87), P <0.0001]; OS favored robotic over open surgery [0.78 (0.72, 0.85), P <0.0001]. Low-anterior resection: OS significantly favored robotic over laparoscopic [0.76 (0.63, 0.91), P =0.004] and open surgery [0.83 (0.74, 0.93), P =0.001]. CONCLUSIONS: Long-term outcomes were similar for robotic versus laparoscopic/thoracoscopic and open surgery, with no safety signal or indication requiring further research (PROSPERO Reg#CRD42021240519).

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Leitao MM, Kreaden US, Laudone V, et al. The RECOURSE Study: Long-term Oncologic Outcomes Associated With Robotically Assisted Minimally Invasive Procedures for Endometrial, Cervical, Colorectal, Lung, or Prostate Cancer: A Systematic Review and Meta-analysis. Ann Surg. 2022. PMID: 36073772. doi:10.1097/SLA.0000000000005698

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。